427 related articles for article (PubMed ID: 34538015)
1. Platelets contribute to disease severity in COVID-19.
Barrett TJ; Bilaloglu S; Cornwell M; Burgess HM; Virginio VW; Drenkova K; Ibrahim H; Yuriditsky E; Aphinyanaphongs Y; Lifshitz M; Xia Liang F; Alejo J; Smith G; Pittaluga S; Rapkiewicz AV; Wang J; Iancu-Rubin C; Mohr I; Ruggles K; Stapleford KA; Hochman J; Berger JS
J Thromb Haemost; 2021 Dec; 19(12):3139-3153. PubMed ID: 34538015
[TBL] [Abstract][Full Text] [Related]
2. Platelet gene expression and function in patients with COVID-19.
Manne BK; Denorme F; Middleton EA; Portier I; Rowley JW; Stubben C; Petrey AC; Tolley ND; Guo L; Cody M; Weyrich AS; Yost CC; Rondina MT; Campbell RA
Blood; 2020 Sep; 136(11):1317-1329. PubMed ID: 32573711
[TBL] [Abstract][Full Text] [Related]
3. Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19.
Zhu A; Real F; Capron C; Rosenberg AR; Silvin A; Dunsmore G; Zhu J; Cottoignies-Callamarte A; Massé JM; Moine P; Bessis S; Godement M; Geri G; Chiche JD; Valdebenito S; Belouzard S; Dubuisson J; Lorin de la Grandmaison G; Chevret S; Ginhoux F; Eugenin EA; Annane D; Bordé EC; Bomsel M
Cell Mol Life Sci; 2022 Jun; 79(7):365. PubMed ID: 35708858
[TBL] [Abstract][Full Text] [Related]
4. Immature platelets in patients with Covid-19: association with disease severity.
Cohen A; Harari E; Yahud E; Cipok M; Bryk G; Lador NK; Mann T; Mayo A; Lev EI
J Thromb Thrombolysis; 2021 Oct; 52(3):708-714. PubMed ID: 34519015
[TBL] [Abstract][Full Text] [Related]
5. Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond.
Sciaudone A; Corkrey H; Humphries F; Koupenova M
Circ Res; 2023 May; 132(10):1272-1289. PubMed ID: 37167360
[TBL] [Abstract][Full Text] [Related]
6. Platelets and COVID-19.
Rohlfing AK; Rath D; Geisler T; Gawaz M
Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
[TBL] [Abstract][Full Text] [Related]
7. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.
Zaid Y; Puhm F; Allaeys I; Naya A; Oudghiri M; Khalki L; Limami Y; Zaid N; Sadki K; Ben El Haj R; Mahir W; Belayachi L; Belefquih B; Benouda A; Cheikh A; Langlois MA; Cherrah Y; Flamand L; Guessous F; Boilard E
Circ Res; 2020 Sep; 127(11):1404-18. PubMed ID: 32938299
[No Abstract] [Full Text] [Related]
8. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?
Campbell RA; Boilard E; Rondina MT
J Thromb Haemost; 2021 Jan; 19(1):46-50. PubMed ID: 33119197
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype.
Bongiovanni D; Klug M; Lazareva O; Weidlich S; Biasi M; Ursu S; Warth S; Buske C; Lukas M; Spinner CD; Scheidt MV; Condorelli G; Baumbach J; Laugwitz KL; List M; Bernlochner I
Cell Death Dis; 2021 Jan; 12(1):50. PubMed ID: 33414384
[TBL] [Abstract][Full Text] [Related]
10. Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19.
Maugeri N; De Lorenzo R; Clementi N; Antonia Diotti R; Criscuolo E; Godino C; Tresoldi C; Angels For Covid-BioB Study Group B; Bonini C; Clementi M; Mancini N; Ciceri F; Rovere-Querini P; Manfredi AA
J Thromb Haemost; 2022 Feb; 20(2):434-448. PubMed ID: 34710269
[TBL] [Abstract][Full Text] [Related]
11. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
Barale C; Melchionda E; Morotti A; Russo I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
[TBL] [Abstract][Full Text] [Related]
12. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.
Hottz ED; Azevedo-Quintanilha IG; Palhinha L; Teixeira L; Barreto EA; Pão CRR; Righy C; Franco S; Souza TML; Kurtz P; Bozza FA; Bozza PT
Blood; 2020 Sep; 136(11):1330-1341. PubMed ID: 32678428
[TBL] [Abstract][Full Text] [Related]
13. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
Nicolai L; Leunig A; Brambs S; Kaiser R; Weinberger T; Weigand M; Muenchhoff M; Hellmuth JC; Ledderose S; Schulz H; Scherer C; Rudelius M; Zoller M; Höchter D; Keppler O; Teupser D; Zwißler B; von Bergwelt-Baildon M; Kääb S; Massberg S; Pekayvaz K; Stark K
Circulation; 2020 Sep; 142(12):1176-1189. PubMed ID: 32755393
[TBL] [Abstract][Full Text] [Related]
14. Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure.
Campo G; Contoli M; Fogagnolo A; Vieceli Dalla Sega F; Zucchetti O; Ronzoni L; Verri M; Fortini F; Pavasini R; Morandi L; Biscaglia S; Di Ienno L; D'Aniello E; Manfrini M; Zoppellari R; Rizzo P; Ferrari R; Volta CA; Papi A; Spadaro S
Platelets; 2021 May; 32(4):560-567. PubMed ID: 33270471
[TBL] [Abstract][Full Text] [Related]
15. Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation.
Jakobs K; Reinshagen L; Puccini M; Friebel J; Wilde AB; Alsheik A; Rroku A; Landmesser U; Haghikia A; Kränkel N; Rauch-Kröhnert U
Front Immunol; 2022; 13():844701. PubMed ID: 35359931
[TBL] [Abstract][Full Text] [Related]
16. Alterations in platelets during SARS-CoV-2 infection.
Brambilla M; Canzano P; Becchetti A; Tremoli E; Camera M
Platelets; 2022 Feb; 33(2):192-199. PubMed ID: 34384321
[TBL] [Abstract][Full Text] [Related]
17. Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
Apostolidis SA; Sarkar A; Giannini HM; Goel RR; Mathew D; Suzuki A; Baxter AE; Greenplate AR; Alanio C; Abdel-Hakeem M; Oldridge DA; Giles JR; Wu JE; Chen Z; Huang YJ; Belman J; Pattekar A; Manne S; Kuthuru O; Dougherty J; Weiderhold B; Weisman AR; Ittner CAG; Gouma S; Dunbar D; Frank I; Huang AC; Vella LA; ; Reilly JP; Hensley SE; Rauova L; Zhao L; Meyer NJ; Poncz M; Abrams CS; Wherry EJ
Front Immunol; 2022; 13():834988. PubMed ID: 35309299
[TBL] [Abstract][Full Text] [Related]
18. Cardiac megakaryocytes in SARS-CoV-2-positive autopsies.
Gawelek KL; Padera R; Connors J; Pinkus GS; Podznyakova O; Battinelli EM
Histopathology; 2022 Nov; 81(5):600-624. PubMed ID: 35925828
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated platelet function in patients with postacute sequelae of COVID-19.
Aggarwal A; Singh TK; Pham M; Godwin M; Chen R; McIntyre TM; Scalise A; Chung MK; Jennings C; Ali M; Park H; Englund K; Khorana AA; Svensson LG; Kapadia S; McCrae KR; Cameron SJ
Vasc Med; 2024 Apr; 29(2):125-134. PubMed ID: 38334067
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells.
Puhm F; Allaeys I; Lacasse E; Dubuc I; Galipeau Y; Zaid Y; Khalki L; Belleannée C; Durocher Y; Brisson AR; Wolberg AS; Langlois MA; Flamand L; Boilard E
Blood Adv; 2022 Jun; 6(12):3593-3605. PubMed ID: 35443030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
